A second industry report (PDF) also came out this week. The Healthcare Group Purchasing Industry Initiative, a voluntary organization that monitors the ethical and business practices of some GPOS, on Monday released its annual report. The initiative was formed in 2005 by GPOs to offset concerns among some members of Congress about their business practices.
Both reports seek to defend GPOs' role maintaining ethical contracting practices with hospitals, medical suppliers and drug companies while also promoting the GPOs' position helping hospitals preserve and lower supply costs.
The GAO report, expected to be released in November, was requested in 2012 by Sen. Ed Markey (D-Mass.) and five other members of Congress over concerns that the contracting practices of GPOs contributed to the ongoing drug shortage crisis in the U.S. and the ensuing reliance on compounding pharmacies. Compounded drugs became a subject of intense scrutiny when a contaminated batch of methylprednisolone acetate was distributed to 20 states and sickened hundreds of people. Sixty-four people died.
In a Nov. 2012 letter to GAO Acting Comptroller General Gene Dodaro, the lawmakers suggested exclusionary contracts and high fees between GPOs and generic drug makers have caused some manufacturers to exit the market because there is little incentive to continue doing making those drugs. When a sole-source manufacturer of a drug faces a recall or shutdown then, it can cause a shortage.
HSCA President Curtis Rooney has said previously that any attempt to link GPOs to drug shortages is an “irresponsible and dangerous distraction.” GPOs say shortages are a result of manufacturing and quality issues.
Applied Policy, a Washington-based health policy firm that conducted the survey on behalf of the HSCA, gathered information from five GPOs: Amerinet, based in St. Louis; HealthTrust, in Brentwood, Tenn.; MedAssets in Alpharetta, Ga.; Novation, in Irving, Texas; and Premier, in Charlotte, N.C. The report was publicized at the trade group's annual expo last week in Washington.
“As payment reforms from both public and private payers have migrated away from a more traditional fee-for-service system to a prospective, or bundled payment system, hospitals face increased pressure to reduce costs,” the authors concluded. “GPOs have proven to be valuable partners supporting virtually every hospital across the country.”